Cannabis has been illegal in Japan since 1948.
Under the current legislations defined by the Cannabis Control Law, its use and possession can be punished with five years of imprisonment on top of heavy financial penalties. In addition, anyone found involved in the cultivation, sale or transport of the drug can land in jail for about 7 to 10 years and made liable to pay a hefty fine to authorities.
These stringent policies have led to a lot of stigmatization of cannabis in Japan. According to some legalization advocates in the country, this stigma is so strong that it can be analogous to pillory surrounding criminals.
This criminalization of the plant has led to a complete shift in social attitudes towards it. Therefore, in order to bring about policy reforms in the industry, many advocates consider raising public awareness about the drug as the most vital course of action.
History of cannabis use in Japan
A historical review of cannabis use in Japan reveals that it was cultivated in the region since the pre-Neolithic period. This means that it was associated with the culture of the region since thousands of years.
If that period seems too ancient to consider, data from 1954 can be far more convincing. According to statistics reported in Medical Cannabis Network Quarterly, there were about 37,313 hemp farmers in Japan in 1954, compared to barely 37 in 2016.
Therefore, it can be established that cannabis was a popular agricultural product in the country back in the day.
Before its US influenced legal ban in 1948, the plant was widely used in the country. It was also considered sacred. The followers of the Shinto religious tradition believed that cannabis had the power of purification. They also respected it as a symbol of the sun, the inspiration for the Japanese flag.
In addition to this, cannabis was widely used in producing fiber and various other products. According to Junichiro Takayasu, director of Japan’s only cannabis museum, “The cannabis-fiber weaving technique used by Japanese craftsmen is very conscientious handwork, and I think it is important to carry on the tradition. The clothes from genuine cannabis fiber are cool in summer and warm in the winter, which is perfect for the Japanese climate.”
Struggling for cannabis acceptance and legalization
Despite of the strict laws surrounding the cannabis industry, groups of legalization advocates are emerging in the country. Green Zone Japan and Japanese Clinical Association of Cannabinoids are among the most prominent names that are striving to secure a legal status for cannabis in the country.
Aim of Green Zone Japan
Green Zone Japan is a medical cannabis advocacy group that came into being in 2017. The main aim of the founders Naoko Miki and Yuji Masakata is to bring up to date medical cannabis information to Japanese medical professionals and the general public in order to educate them on the subject.
In a recent move towards its legalizing efforts, Green Zone is adding subtitles to a documentary called CBD Nation. The documentary will be virtually screened for members all year long for maximum viewership.
Aim of Japanese Clinical Association of Cannabinoids
Japanese Clinical Association of Cannabinoids is the official partner of the International Association for Cannabinoid Medicines. It was established in 2015 to aid healthcare workers in conducting cannabinoid researches in Japan.
They are working to analyze and evaluate CBD clinical researches and the effects of foods infused with it.
Businesses using cannabis derivative, CBD
The lack of awareness about therapeutic benefits of CBD and the stringent laws have negatively affected businesses in the country.
It was among the most important agricultural crops when a complete ban was placed on it. The resulting outrage and disapproval by the most hard hit farmers forced the government to revise the laws. What we see today is the “revised” version due to the retaliation.
Today, cultivation of hemp is still possible, but under the strict control of the government. Growers have to obtain a cultivation license and permission before they can begin plantation. The bureaucratic process for obtaining and maintaining a license is so long and tiresome that agricultures are discouraged.
Despite of this, Japan is advancing small steps towards cannabis normalization. Entrepreneurs like Kota Shimomura, owner of CBD Coffee in Tokyo’s Meguro Ward, are giving new business ideas and clientele to the cannabis industry. Due to the increasing demand, he believes that the CBD market will surpass tobacco in the nest five years. He is also planning to open a second location in Shinjuku by the end of this year.
Then there is another line of beauty products launched by Priyanka Yoshikawa, a model and former Miss World Japan. “I wanted to have my own skin care line for a long time. And I saw that no one was really doing a good, CBD-based skin care line.” She also believes that CBD will provide the much needed relief to the workaholic population of Japan. It will allow them some “relaxation and one-on-one time”.
This industry is expected to bring in a lot of job opportunities for it agricultural revival. According to Masakata, a neurologist by profession and volunteer at Green Zone, this revival will bring young people to come back to the countryside.
Cannabis Oil Effectively Reduces Chronic Pain
The use of cannabis oil and other medical items containing marijuana legal since 2018 in the UK. However, the evidence of marijuana being efficacious has come under light recently. Researchers are discovering the effectiveness of marijuana oil in chronic pain patients.
Multiple studies occurred to determine the effectiveness of cannabis oil. Patients receiving marijuana as part of their treatment feel much better and experience improvement in their health.
Gathering Evidence Of Cannabis Oil Being Effective For Chronic Pain Patients
The United Kingdom Medical Cannabis Registry enrolls one hundred and ten patients. The purpose of enrolling these patients was to observe the effectiveness of cannabis oil. Moreover, through these patients, the impact of marijuana on overall improving quality of life was determined.
The registry reports that enrolled patients feel much better after one, three, and six months of cannabis oil intake. They experience that their pain reduces after using medical pot. They experience comfort, and their sleep quality has improved hugely. According to the registry, there are significant improvements in patients’ health-associated quality of life.
The National Health Service of the United Kingdom has a strict cannabis oil prescription policy. It is hard for patients to get a marijuana prescription because of the strict rules of the NHS. Patients who don’t respond well to conventional therapy have access to medical marijuana. The conditions under which patients can access medical marijuana include pain sufferers, individuals with anxiety issues, and multiple sclerosis.
About sixty-five percent of the patients part of the study had never used cannabis oil or medical marijuana. The participants are primarily diagnosed with chronic non-cancer pain, neuropathic pain, and fibromyalgia.
16% of the participants suffered from fibromyalgia and 48% percent from chronic non-cancer pain. Twenty-four percent of the participants are suffering from neuropathic pain.
Experts Focus On Research
For the betterment of society and its safety, it is vital to gather research-based evidence. Doctors and scientists consider it essential to discover the realities of using cannabis before prescribing it.
Dr. Simon Erridge is the head of research at Sapphire Medical Clinics. In a statement, he said that the number of medical marijuana prescriptions is increasing quickly in the UK. In this situation, it is essential to determine the outcomes of patients. Collecting real-world practical evidence regarding cannabis oil consumption is vital.
According to Dr. Simon, this research that they conducted is one of a kind in Europe. His team will continuously review inpatients, outpatients, and marijuana products via the Medical Cannabis Registry UK. So far, the selection of observational data has occurred. In the future, more critical research, including randomized controlled investigations, will occur.
Sapphire Medical Clinics developed the registry. They survey patients suffering from various diseases receiving separate prescriptions depending upon their condition. Surveying these individuals enables us to reduce the knowledge gap.
Filling the blank space regarding medical marijuana and cannabis oil in scientific knowledge helps a lot. The study’s findings were published in the well-known scientific journal, the Journal of Clinical Pharmacology.
The research does prove that medical marijuana is effective in improving multiple conditions of people. But researchers require more research to form guidelines, funders, and licensing agencies.
Adven is a subsidiary of Curaleaf International. It is one of the largest independent marijuana companies in Europe. Adven cannabis oil was used in studies such that the average CBD dose was 20mg per day. The average THC dose that participants get is 1mg per day. Administration of cannabis oil occurs in a ratio CBD/THC of 20 to 1.
More participants enrolled in the survey process. Sapphire Medical Clinic plans to continue its survey-based research.
Oklahoma On Its Way To Legalize Marijuana And Alter Medical Cannabis Reforms
Activists in Oklahoma are filling marijuana legalization. For the 2022 ballot, they are willing to introduce medical cannabis reform. On Thursday, the activists of the state legalized adult-use weed products. Moreover, they remodel the existing medical pot program of the state.
The activists formally introduced the measures to the secretary of state’s office. After the signature-gathering, the constitutional amendments will occur.
Last month, Oklahomans for Responsible Cannabis Action (ORCA) announced late that it was close to finalizing the language of the initiatives. The final set of amendments occurs after soliciting feedback from a wide range of advocates and stakeholders.
Medical Cannabis Reforms
Medical cannabis reforms in the state have many flaws and loopholes that lead to problems. Jed Green is the director of ORCA. According to Jed, the initiatives the activists are introducing are to fix the issues that have emerged in the state’s medical marijuana program.
The amendments and new policies will also generate opportunities for the weed industry with adult-use legalization. According to Jed, these initiatives will enable the people of Oklahomans to keep operating the marijuana business successfully.
New Marijuana Policies
Under the new policy, individuals 21 or above will have permission to keep eight ounces of marijuana. They can purchase such an amount from any legal retailer or dispenser. The new policy also allows one person to own 12 plants of cannabis for personal use.
The new reforms suggest imposing a fifteen percent excise tax on the sale of weed products. There are multiple numbers of programs that will receive revenue generated from those taxes.
After deducting the implementation cost, the rest of the money is divided into various programs. These programs include water-related infrastructure, substance misuse treatment programs, people with abnormalities or disabilities, and many more.
Some of the revenue money will be for law enforcement training and cannabis research projects. The initiatives have measures for those that have faced resentencing for marijuana convictions.
What is new in Oklahoma Medical Cannabis Reforms?
In 2018 voters in Oklahoma approved medical cannabis programs are open for any patient. Unlike other states, Oklahomans patients do not need to fulfill specific qualifying conditions. In addition, physicians and doctors can prescribe medical weed products to anyone they think is fit to use.
Activists suggest establishing a new OSCC Oklahoma Cannabis Commission. The aim of establishing the OSCC is to build a commission that will oversee everything regarding the state medical marijuana program.
The new policy also suggests imposing a seven percent excise tax. The authorities will utilize revenue money from the sale of these items in supporting weed research. It will be for rural impact and urban waste remediation.
Part of the revenue will also be for agriculture development and treatment programs designed for substance use disorder patients. Gross income from the sale of medical cannabis will support mental health response programs.
The tax on medical hemp products will decrease to zero gradually within one year of the enactment of initiatives. Once the proposed constitution is under-enactment, medical marijuana dispensaries will have permission to sell recreational pot items. However, it will begin within 60 days of ordinance enactment.
The activists have previously attempted to qualify some cannabis legalization measures for the 2020 ballot. But, due to less support, those measures were never put to action. To get signatures of the majority to approve ballot 2022 is essential to introduce the new medical cannabis reforms and legalize marijuana for adult use.
Without sufficient support from registered voters, new policies can never become a reality.
New York Cannabis Board Relaxes Medical Cannabis Rules
New York State approves recreational and medical cannabis by passing the bill of decriminalizing and legalizing marijuana. Initially, the process got delayed, but now things are moving a step forward in implementing the bill. Governor Andrew Cuomo and legislators approve of the marijuana control board.
The cannabis control board, after its formation, conducted its first meeting on Tuesday. Five members of the board are taking a step closer to the commencement of legalized marijuana retail sales.
What Changes Does The State Cannabis Board Make?
The members agree to make an official announcement of immediately relaxing rules governing the state’s medical-marijuana program. The control board expands the number of people who can prescribe medical cannabis. Now anyone from dentists to midwives can prescribe marijuana as medication.
The control board permits the sale of weed flowers. It will make the drug available to people in a smokeable format. Moreover, it will lower the high prices of medical weed items in New York.
Tremaine Wright is the chair of the NewYork State’s Cannabis Control Board. The mandate of the board is to make medical marijuana accessible for patients and improve patient care. Tremaine elaborates that the board takes their mandate very seriously and will immediately work on fulfilling it.
Changes In The Medical Cannabis Program
In the first quarter of 2021, legislators made some changes to the medical marijuana program. Previously, the program authorized 150000 New Yorkers to only get access to medical cannabis for various health reasons. It is uncertain how many of the certified people are still using pot. It is unknown how many have died of terminal diseases.
Of the certified people, some people have abandoned the use of marijuana due to cost issues. Some stopped their program because of the inaccessibility of weed in New York.
Lawmakers urge the control board not to delay medical cannabis program changes. Crystal Peoples-Stokes is the Assembly Majority Leader. Stokes, the Assembly marijuana law sponsor, and a Buffalo Democrat were among those who requested quick changes. Legislators are requested to make the necessary changes to the program before beginning the process of allowing recreational marijuana sales.
Decisions regarding recreational pot, policymaking, and implementation of its rules can occur within 18 months. The state has time of 18 months before recreational marijuana sales begin in New York State. But before that, rules regarding pot as medication must undergo some alterations immediately.
What More Is On Marijuana?
The Office of Cannabis Management has decriminalized for people 21 and older the ownership of about 3 ounces of marijuana. However, the sale of weed is still illegal in the state. The control board or agency also controls the hemp industry along with the recreational and medical cannabis industry.
About 3400 healthcare professionals have permission to prescribe medical marijuana to patients that are certified or eligible. These professionals include physicians, nurse practitioners, dentists, midwives, and some assistants of physicians.
The change that led to the expansion of health care professionals who can prescribe medical marijuana passed on Tuesday. It increases the number of prescribers that are recommending the drug. Now anyone with a license to dispense controlled substances can prescribe medical cannabis.
The board increases the supply of marijuana for dispensing. It decreases the $50 registration fee of the patient and caregiver. It makes it easy for facilities such as hospitals to hand out medical cannabis to patients.
According to officials, allowing the sale of raw flowers instead of refined final formulations of marijuana will decrease production costs. As a result, it will reduce the cost of medical cannabis for patients. However, the entire marijuana plant sale will not begin on the 38 medical pot dispensaries right away. They will have to practice some quality control measures to start selling the drug.
Cannabis2 years ago
How CBD oil works?
Cannabis2 years ago
CBD Gummies: How does it work? Benefits, Pricing and Packages
Health2 years ago
Diabetes Freedom Review – A Natural Way To Beat Diabetes Type 2
Cannabis3 years ago
Research Suggests Cannabis Effective in Treating Endometriosis
Cannabis2 years ago
Why cannabis should be legal?
Featured2 years ago
Prosper Wellness TurmeriCBD Review – A combination of Turmeric and CBD?
Health2 years ago
VitaMove, a Popular Formula to Relieve Back Pain is Restocked
Cannabis2 years ago
What are the main advantages of consuming CBD oil?